It has been reported that a YAP analog, namely 17-peptide (147, 148), has now been designed with a super-inhibitory effect on YAP-TEAD-1 and a significant inhibition of tumor proliferation in an ovarian cancer animal model (149). Here, YAP1 is linked to ovarian carcinoma.